デフォルト表紙
市場調査レポート
商品コード
1211914

イムノアッセイシステムの世界市場

Immunoassay Systems

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 267 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.28円
イムノアッセイシステムの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 267 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のイムノアッセイシステムの市場規模は、2022年の221億米ドルから2030年までに299億米ドルに達し、分析期間の2022年~2030年にCAGRで3.8%の成長が予測されています。

当レポートでは、世界のイムノアッセイシステム市場について調査分析し、市場の動向と促進要因、地域分析、競合情勢などを提供しています。

調査対象企業の例(全29社):

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Tosoh Bioscience Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場の概要
  • 主要企業
  • 市場の動向と促進要因
  • 世界市場の見通し

第3章 市場の分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他の欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他の中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3522

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Immunoassay Systems Market to Reach $29.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Immunoassay Systems estimated at US$22.1 Billion in the year 2022, is projected to reach a revised size of US$29.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$19.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analyzers / Instruments segment is readjusted to a revised 3.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6 Billion, While China is Forecast to Grow at 6.6% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4 Billion by the year 2030.

Select Competitors (Total 29 Featured):

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Tosoh Bioscience Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Immunoassay Systems: An Introductory Prelude
    • Recent Market Activity
    • Steady Growth Projected for World Immunoassay Systems Market
    • Expanding Applications Boost Market Prospects
    • Northbound Trajectory in Healthcare Spending Underpins Value Growth
    • Developed Regions - Primary Revenue Contributors
    • Fast Paced Growth Forecasts in Developing Regions
    • Expansion in Healthcare Infrastructure & Rising Healthcare Awareness Fuel Demand in Developing Regions
    • Immunoassay Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • Beckman Coulter, Inc. (USA)
    • bioMerieux SA (France)
    • Bio-Rad Laboratories Inc. (USA)
    • DiaSorin S.p.A (Italy)
    • Fujirebio, Inc. (Japan)
    • Ortho-Clinical Diagnostics, Inc. (USA)
    • Quidel Corporation (USA)
    • Roche Diagnostics (Switzerland)
    • Siemens Healthineers (USA)
    • Sysmex Corporation (Japan)
    • Tosoh Bioscience Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Bespoke Solutions Energize Market Growth
    • Multiplex Immunoassays Accelerate Overall Market Expansion
    • ELISA - Preferred Immunoassay Test in Research and Diagnostic Applications
    • Automation of ELISA - Enabling its Sustenance
    • Growing Popularity of Multiplexing Deters ELISA Market
    • Commoditization: A Key Issue Facing ELISA Product Manufacturers
    • Chemiluminescence Immunoassays Gain Prominence
    • Waning Demand for Radioimmunoassay Systems
    • Immunoassays Solidify their Role in Biomarker Detection
    • SERS - An Attractive Readout Strategy
    • Automated Immunoassay Systems - In Line with Automation Trend
    • Point-of-Care (POC) and Digital immunoassay (DIA) Systems Make Substantial Gains
    • Miniaturization Aids Roll Out of Sophisticated POC and DIA Systems
    • Ultra-Sensitive Platforms Set to Proliferate the Market
    • Infectious Disease Diagnosis - Primary Application Area
    • Increasing Incidence of Infectious Diseases - An Opportunity Indicator
    • Growing Significance in Cancer Care
    • Sustained Opportunities in Endocrine Testing Procedures
    • Diabetes Testing
    • Prenatal Testing
    • Vital Role in Blood Processing Applications
    • Blood Grouping and Typing
    • Food Sciences and Quality Control Offer Robust Growth Verticals
    • Growing Prominence of Immunoassays in New & Niche Application Verticals: A Review
    • Environmental Testing
    • Drugs of Abuse Testing (DAT)
    • Therapeutic Drug Monitoring (TDM)
    • Immune Diseases
    • Expanding Use Case in Biomedical Research Processes Amplifies Demand
    • Consolidation of Hospitals and Labs Triggers Robust Growth Opportunities
    • Rising Medical Needs of Aging Population - A Market Driver
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Rapid Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Analyzers / Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Radioimmuno Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 27: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 30: World 18-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 33: World 18-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 36: World 18-Year Perspective for Pharmaceutical & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 39: World 18-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 40: World Immunoassay Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: USA 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: USA 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: USA 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Canada 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Canada 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Canada 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • JAPAN
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Japan 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Japan 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Japan 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • CHINA
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: China 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: China 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: China 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • EUROPE
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Europe 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Immunoassay Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Europe 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Europe 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Europe 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • FRANCE
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: France 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: France 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: France 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • GERMANY
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Germany 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Germany 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Germany 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 109: Italy 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 112: Italy 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 115: Italy 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 118: UK 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 121: UK 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 124: UK 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 127: Spain 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 130: Spain 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 133: Spain 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 136: Russia 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 139: Russia 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 142: Russia 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 145: Rest of Europe 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 148: Rest of Europe 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 154: Asia-Pacific 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Immunoassay Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 157: Asia-Pacific 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 166: Australia 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 169: Australia 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 172: Australia 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • INDIA
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 175: India 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 178: India 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 181: India 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 184: South Korea 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 187: South Korea 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 190: South Korea 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 202: Latin America 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Immunoassay Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 205: Latin America 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 208: Latin America 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 211: Latin America 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 214: Argentina 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 217: Argentina 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 220: Argentina 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 223: Brazil 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 226: Brazil 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 229: Brazil 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 232: Mexico 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 235: Mexico 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 238: Mexico 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 241: Rest of Latin America 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 244: Rest of Latin America 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 247: Rest of Latin America 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 250: Middle East 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Immunoassay Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 253: Middle East 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 256: Middle East 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 259: Middle East 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 262: Iran 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 265: Iran 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 268: Iran 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 271: Israel 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 274: Israel 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 277: Israel 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 280: Saudi Arabia 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 283: Saudi Arabia 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 286: Saudi Arabia 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 289: UAE 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 292: UAE 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 295: UAE 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 298: Rest of Middle East 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 301: Rest of Middle East 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 304: Rest of Middle East 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030
  • AFRICA
    • Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 307: Africa 18-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2012, 2023 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 310: Africa 18-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2012, 2023 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 313: Africa 18-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2012, 2023 & 2030

IV. COMPETITION